Flutiform 250 mikrograma/10 mikrograma po potisku, stlačeni inhalat, suspenzija
| Name | Flutiform 250 mikrograma/10 mikrograma po potisku, stlačeni inhalat, suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-341378137 |
| Active Substance | flutikazonpropionat formoterolfumarat dihidrat |
| Composition | jedna odmjerena doza (doza koja izlazi iz ventila) sadrži: 250 mikrograma flutikazonpropionata i 10 mikrograma formoterolfumarat dihidrata, što odgovara isporučenoj dozi (dozi koja se oslobađa iz aktivatora) od približno 230 mikrograma flutikazonpropionata i 9 mikrograma formoterolfumarat dihidrata. |
| Pharmaceutical Form | stlačeni inhalat, suspenzija |
| Manufacturer | Mundipharma DC B.V., Leusden, Nizozemska |
| Marketing Authorisation Holder | Mundipharma Gesellschaft m.b.H., Wiedner Gurtel 13, Turm 24, OG 15, Beč, Austrija |
| Marketing Authorisation Date | 10.03.2020 |
| MA Period of Validity | 10.03.2025 |
| Classification Number | UP/I-530-09/19-01/246 |
| Registration Number | 381-12-01/70-20-05 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | R03AK11 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
